Clinically isolated syndromes suggestive of multiple sclerosis, part 2: Non-conventional MRI, recovery processes, and management

David Miller, Frederik Barkhof, Xavier Montalban, Alan Thompson, Massimo Filippi

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

The onset of multiple sclerosis (MS) in 85% of young adults is with a subacute clinically isolated syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Whereas multifocal brain lesions are present on MRI in many patients with a CIS, some patients have additional abnormalities on quantitative MRI in otherwise normal-appearing white and grey matter that suggest an extensive pathological process. Functional outcome for patients with symptomatic CIS lesions is determined by the interplay of inflammation, demyelination, axonal damage, remyelination, and cortical adaptation. Recovery of function may be accelerated by high dose corticosteroids, and although interferon beta delays the development of a second relapse, its long-term effect is unknown. A better understanding of pathological and pathogenetic processes in patients with a CIS will facilitate the development of disease-modifying treatments for patients with MS before they become disabled. Continued clinical and laboratory investigation of patients with a CIS should be encouraged.

Original languageEnglish
Pages (from-to)341-348
Number of pages8
JournalThe Lancet Neurology
Volume4
Issue number6
DOIs
Publication statusPublished - Jun 1 2005

Fingerprint

Multiple Sclerosis
Pathologic Processes
Interferon-beta
Recovery of Function
Demyelinating Diseases
Optic Nerve
Brain Stem
Young Adult
Spinal Cord
Adrenal Cortex Hormones
Inflammation
Recurrence
Brain

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Clinically isolated syndromes suggestive of multiple sclerosis, part 2 : Non-conventional MRI, recovery processes, and management. / Miller, David; Barkhof, Frederik; Montalban, Xavier; Thompson, Alan; Filippi, Massimo.

In: The Lancet Neurology, Vol. 4, No. 6, 01.06.2005, p. 341-348.

Research output: Contribution to journalArticle

Miller, David ; Barkhof, Frederik ; Montalban, Xavier ; Thompson, Alan ; Filippi, Massimo. / Clinically isolated syndromes suggestive of multiple sclerosis, part 2 : Non-conventional MRI, recovery processes, and management. In: The Lancet Neurology. 2005 ; Vol. 4, No. 6. pp. 341-348.
@article{904c98ff028b4cb9816536fa168537fa,
title = "Clinically isolated syndromes suggestive of multiple sclerosis, part 2: Non-conventional MRI, recovery processes, and management",
abstract = "The onset of multiple sclerosis (MS) in 85{\%} of young adults is with a subacute clinically isolated syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Whereas multifocal brain lesions are present on MRI in many patients with a CIS, some patients have additional abnormalities on quantitative MRI in otherwise normal-appearing white and grey matter that suggest an extensive pathological process. Functional outcome for patients with symptomatic CIS lesions is determined by the interplay of inflammation, demyelination, axonal damage, remyelination, and cortical adaptation. Recovery of function may be accelerated by high dose corticosteroids, and although interferon beta delays the development of a second relapse, its long-term effect is unknown. A better understanding of pathological and pathogenetic processes in patients with a CIS will facilitate the development of disease-modifying treatments for patients with MS before they become disabled. Continued clinical and laboratory investigation of patients with a CIS should be encouraged.",
author = "David Miller and Frederik Barkhof and Xavier Montalban and Alan Thompson and Massimo Filippi",
year = "2005",
month = "6",
day = "1",
doi = "10.1016/S1474-4422(05)70095-8",
language = "English",
volume = "4",
pages = "341--348",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "6",

}

TY - JOUR

T1 - Clinically isolated syndromes suggestive of multiple sclerosis, part 2

T2 - Non-conventional MRI, recovery processes, and management

AU - Miller, David

AU - Barkhof, Frederik

AU - Montalban, Xavier

AU - Thompson, Alan

AU - Filippi, Massimo

PY - 2005/6/1

Y1 - 2005/6/1

N2 - The onset of multiple sclerosis (MS) in 85% of young adults is with a subacute clinically isolated syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Whereas multifocal brain lesions are present on MRI in many patients with a CIS, some patients have additional abnormalities on quantitative MRI in otherwise normal-appearing white and grey matter that suggest an extensive pathological process. Functional outcome for patients with symptomatic CIS lesions is determined by the interplay of inflammation, demyelination, axonal damage, remyelination, and cortical adaptation. Recovery of function may be accelerated by high dose corticosteroids, and although interferon beta delays the development of a second relapse, its long-term effect is unknown. A better understanding of pathological and pathogenetic processes in patients with a CIS will facilitate the development of disease-modifying treatments for patients with MS before they become disabled. Continued clinical and laboratory investigation of patients with a CIS should be encouraged.

AB - The onset of multiple sclerosis (MS) in 85% of young adults is with a subacute clinically isolated syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Whereas multifocal brain lesions are present on MRI in many patients with a CIS, some patients have additional abnormalities on quantitative MRI in otherwise normal-appearing white and grey matter that suggest an extensive pathological process. Functional outcome for patients with symptomatic CIS lesions is determined by the interplay of inflammation, demyelination, axonal damage, remyelination, and cortical adaptation. Recovery of function may be accelerated by high dose corticosteroids, and although interferon beta delays the development of a second relapse, its long-term effect is unknown. A better understanding of pathological and pathogenetic processes in patients with a CIS will facilitate the development of disease-modifying treatments for patients with MS before they become disabled. Continued clinical and laboratory investigation of patients with a CIS should be encouraged.

UR - http://www.scopus.com/inward/record.url?scp=19344367787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19344367787&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(05)70095-8

DO - 10.1016/S1474-4422(05)70095-8

M3 - Article

C2 - 15907738

AN - SCOPUS:19344367787

VL - 4

SP - 341

EP - 348

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 6

ER -